Seneca Biopharma Analysis
Seneca Biopharma is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Seneca Biopharma delisted stock analysis is to determine its intrinsic value, which is an estimate of what Seneca Biopharma is worth, separate from its market price. There are two main types of Seneca Biopharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Seneca Biopharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Seneca Biopharma's stock to identify patterns and trends that may indicate its future price movements.
The Seneca Biopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Seneca Biopharma is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Seneca Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Seneca Biopharma's ongoing operational relationships across important fundamental and technical indicators.
Seneca |
Seneca Stock Analysis Notes
About 14.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.61. Some equities with similar Price to Book (P/B) outperform the market in the long run. Seneca Biopharma recorded a loss per share of 5.64. The entity had not issued any dividends in recent years. The firm had a split on the 18th of July 2019. Seneca Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds. Seneca Biopharma, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. Neuralstem operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 5 people. For more info on Seneca Biopharma please contact the company at 301 366-4841 or go to www.neuralstem.com.Seneca Biopharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Seneca Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Seneca Biopharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Seneca Biopharma is not yet fully synchronised with the market data | |
| Seneca Biopharma has some characteristics of a very speculative penny stock | |
| Seneca Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 15.39 K. Reported Net Loss for the year was (6.63 M) with profit before taxes, overhead, and interest of 260 K. | |
| Seneca Biopharma has about 7.3 M in cash with (6.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of -1.8233. | |
| Roughly 14.0% of the company shares are held by company insiders |
Seneca Market Capitalization
The company currently falls under 'Nano-Cap' category with a total capitalization of 4.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Seneca Biopharma's market, we take the total number of its shares issued and multiply it by Seneca Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Seneca Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Seneca Stock
If you are still planning to invest in Seneca Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seneca Biopharma's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets |